-tic is a foundational Greek-derived suffix in medical terminology with two primary grammatical and clinical functions: forming descriptive adjectives and designating substantive pharmacological agents or clinical entities. Adjectivally, it signifies “pertaining to,” “characterized by,” or “affected with,” serving as the direct adjectival transformation for pathological nouns ending in the suffix -sis (e.g., sclerosis→sclerotic, stenosis→stenotic, thrombosis→thrombotic, necrosis→necrotic, paresis→paretic, and sepsis→septic). Substantively, it functions as a noun-forming suffix denoting a therapeutic substance, pharmaceutical drug, or biological agent possessing a specific mechanism of action (e.g., a diuretic promoting renal fluid excretion, a thrombolytic dissolving intravascular clots, an anesthetic inducing sensory blockade, a hemostatic halting hemorrhage, or a prophylactic preventing disease). In 2026 medical coding, diagnostic statements containing -tic adjectives determine primary disease specificity, acuity, and laterality across cardiology, neurology, and critical care (such as differentiating thrombotic cerebral infarction from embolic stroke), while pharmacological -tic agents dictate procedural and injection code selection in interventional radiology, cardiology, and inpatient care.
Compound adjectival and agentive suffix meaning “pertaining to,” “disposed to,” or “an agent that produces.”
In classical Greek grammar, verbal nouns ending in -sis (designating action, state, or diseased condition) routinely formed their corresponding adjectives in -tikos (e.g., parálysis→paralytikós; sklerōsis→sklērōtikós; thrómbōsis→thrombōtikós). These entered scientific and Late Latin as -ticus and were adopted into Renaissance French as -tique and Middle/Early Modern English as -tic. By the 18th and 19th centuries, as modern pharmacotherapy developed, clinicians substantivized these adjectives into nouns denoting therapeutic classes of drugs (emetic, narcotic, styptic, antiseptic, diuretic). The suffix belongs to the core morphological family of -ic, -etic, -itic, -otic, and -tics (the systematic field or study).
🔀 ALIASES / ALTERNATE TERMS
PERTAINING TO / CHARACTERIZED BY(fundamental adjectival translation for medical and pathological conditions)
PHARMACOLOGICAL AGENT / THERAPEUTIC CLASS(substantive noun descriptor for drugs ending in -tic, e.g., thrombolytic, antiemetic, anesthetic)
-IC / -ETIC / -OTIC(morphological variants and allomorphs denoting identical adjectival relationships across varied Greek stem endings)
PATHOLOGICAL STATE DESCRIPTOR(clinical terminology modifier designating structural and tissue alterations, e.g., necrotic, stenotic, cirrhotic)
AGENTIVE NOUN(grammatical descriptor for biological or chemical substances that induce a specified physiological effect)
đź”— RELATED TERMS
-sis — noun-forming suffix denoting a process, state, or abnormal condition (e.g., thrombosis, stenosis, sclerosis); forms its regular adjective with [[-tic]].
-ic — the parent adjectival suffix meaning “pertaining to” (e.g., cardiac, gastric, chronic).
-itic — adjectival suffix formed from inflammatory nouns ending in -itis (e.g., arthritic, gastritic, nephritic).
thrombolytic — an enzymatic or pharmacological agent capable of dissolving blood clots (e.g., alteplase, tenecteplase; coded under CPT 37211, 92977).
diuretic — an agent that elevates the rate of urination and renal sodium excretion (e.g., loop diuretics administered in congestive heart failure).
Transcatheter therapy, infusion other than for local pain management; cessation of infusion including catheter removal and diagnostic completion angiogram
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance
⚠️ Coding Note: In 2026 medical coding, terms utilizing the [[-tic]] suffix require strict clinical differentiation between underlying pathophysiology, pharmacological administration, and ICD-10-CM sequencing rules:
Sepsis & Septic Shock Sequencing: In inpatient coding, septic shock (R65.21) can never be assigned as the principal diagnosis. Official coding guidelines mandate sequencing the underlying systemic infection first (e.g., sepsis due to Escherichia coli A41.51 or unspecified sepsis A41.9), followed immediately by R65.21, and then any associated acute organ failure codes.
Thrombotic vs. Embolic Stroke: Code selection for ischemic stroke requires provider documentation specifying whether the infarction was thrombotic (I63.30–I63.39) versus embolic (I63.40–I63.49), as well as laterality and specific vascular territory (e.g., right middle cerebral artery). If unspecified, coding defaults to I63.50.
Thrombolytic Therapy Coding: Transcatheter thrombolytic infusion codes (CPT 37211–37214) include all catheter repositioning, radiological supervision and interpretation, flush flushes, and contrast injections performed on the same date of service. Arterial catheterization (e.g., CPT 36245) is separately reportable only when initial selective catheter placement is performed.
Person-First Diagnostic Language: Although historical nomenclature utilized substantivized -tic terms (e.g., “diabetic,” “epileptic”), modern 2026 ICD-10-CM coding mandates capturing the condition as a manifestation or disease state (e.g., “Type 2 diabetes mellitus with diabetic neuropathy” E11.40).